Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5781)
  3. Review (421)
  4. Editorial (196)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13278)
  2. Center for Hematologic Malignancies (10612)
  3. GSK Faculty (4482)
  4. Adult Leukemia (3673)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2705)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (340)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (330)
  5. Haematologica (292)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1530)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A Multicenter experience with single agent bortezomib in non-Hodgkin's lymphoma reveals marked differences in sub-type sensitivity to proteasome inhibition
    Meeting Abstract

    O'connor, O.; Wright, J.; Moskowitz, C.; Macgregor-Cortelli, B.; Straus, D.; Evans, A.; Winter, J.; Koc, O.; Horvath, N.; Blumel, S.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • The paradoxical effect of glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) activation on alloreactive CD4 and CD8 T cells and the development of GVHD
    Meeting Abstract

    Muriglan, S. J.; Ramirez-Montagut, T.; Alpdogan, O.; Van Huystee, T.; Eng, J. M.; Hubbard, V. M.; Kochman, A. A.; Tjoe, K. H.; van den Brink, M. R. M.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Sequential therapy with cytarabine and bismuth-213 (Bi-213)-labeled-HuM195 (anti-CD33) for acute myeloid leukemia (AML)
    Meeting Abstract

    Mulford, D. A.; Pandit-Taskar, N.; McDevitt, M. R.; Finn, R. D.; Weiss, M. A.; Apostolidis, C.; Morgenstern, A.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Bismuth-labeled anti-CD33 antibody for elimination of minimal residual disease in acute myeloid leukemia
    Meeting Abstract

    Mulford, D.; Divgi, C.; Mcdevitt, M.; Sgouros, G.; Finn, R.; Larson, S.; Apostolidis, C.; Morgenstern, A.; Scheinberg, D.; Jurcic, J.
    Cancer Biotherapy and Radiopharmaceuticals (2004)

    Fulltext@MSK | Save
  • The importance of molecular phenotype in predicting overall survival in patients with relapsed or primary refractory DLBCL treated with second-line chemotherapy and ASCT
    Meeting Abstract

    Moskowitz, C. H.; Kewalramani, T.; Hamlin, P.; Nimer, S. D.; Zelenetz, A. D.; Teruya-Feldstein, J.
    Blood (2004)

    Fulltext@MSK | Save
  • Phase I trial of exogenous testosterone (T) for the treatment of castrate metastatic prostate cancer (PC)
    Meeting Abstract

    Morris, M. J.; Kelly, W. K.; Slovin, S.; Sauter, N.; Eicher, C.; Regan, K.; Curley, T.; Delacruz, A.; Reuter, V.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Routine imaging identifies a group of patients with more favorable aggressive NHL at relapse: A retrospective study of a uniformly treated patient population
    Meeting Abstract

    Liedtke, M.; Moskowitz, C. H.; Hamlin, P. A.; Zelenetz, A. D.
    Blood (2004)

    Fulltext@MSK | Save
  • Impact of course of therapy on response rate and duration with the Bexxar® therapeutic regimen (tositumomab and iodine I 131 tositumomab) and with chemotherapy
    Meeting Abstract

    Leonard, J. P.; Zelenetz, A. D.; Vose, J. M.; Kaminski, M. S.
    Blood (2004)

    Fulltext@MSK | Save
  • Pentostatin and cyclophosphamide with or without rituximab has significant activity in patients with previously treated chronic lymphocytic leukemia and other low grade lymphoid neoplasms
    Meeting Abstract

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J.; Scheinberg, D. A.; Gencarelli, A. N.; Horgan, D.; Weiss, M. A.
    Blood (2004)

    Fulltext@MSK | Save
  • MEF regulates hematopoietic stem cell quiescence and hematologic recovery post-myelosuppression
    Meeting Abstract

    Lacorazza, H. D.; Nunes, J.; Nimer, S. D.
    Experimental Hematology (2004)

    Fulltext@MSK | Save